Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

Back to signals Ask the Agent

ELMDBullishEarningsShort Term

High materiality9/10

Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results

StockNews.AIAug 25, 4:05 PM EDT1 source

Trading thesisImportance 9/10

Bullish on ELMD over the next 1–3 quarters as operating leverage compounds.

AI summary

What happened and why it matters

Electromed reported FY2026 revenue of $73.8M, up 15.3%, and operating income of $13.9M (18.8% margin), with Q4 revenue of $19.4M (+11.6%). Direct homecare accelerated 16.3% to $66.6M, supported by a larger sales force and higher per-device revenue, while net income reached $11.3M. The company ended with a cash-rich balance sheet ($20.5M) and no debt, funding a $3.9M stock repurchase and reinforcing long-term growth optionality in the bronchiectasis market via SmartVest.

Record 2026 revenue and expanded operating margin confirm durable profitability.
Debt-free balance sheet with $20.5M cash supports buybacks and potential investments.
Big bronchiectasis opportunity with SmartVest backing sustainable growth.
Stock repurchase signals management confidence; potential multiple expansion.

Sentiment rationale

The company posted durable top-line growth, expanding margins, a debt-free balance sheet, and a meaningful buyback, all of which tend to support upside in the near-to-intermediate term and could lead to multiple expansion if expectations for long-term bronchiectasis market uptake persist.

Key facts

01
Q4 FY2026 revenue rose 11.6% to $19.4M; gross margin 78.7%.
02
FY2026 revenue up 15.3% to $73.8M; operating income $13.9M; margin 18.8%.
03
Direct homecare revenue up 16.3% to $66.6M; avg reps 58; per-rep $1,145,000.
04
Net income FY2026 $11.3M; EPS $1.30; cash from ops $9.7M; no debt.
05
Electromed bought back $3.9M of stock; cash balance $20.5M; bronchiectasis market focus.

Earnings

Earnings; Electromed released its full-year and quarterly results, detailing revenue growth, profitability, and cash metrics, which are core earnings catalysts.